Phase III Clinical Study in Patients With Mild to Severe Scalp Psoriasis
| Status: | Completed |
|---|---|
| Conditions: | Psoriasis |
| Therapuetic Areas: | Dermatology / Plastic Surgery |
| Healthy: | No |
| Age Range: | 18 - 65 |
| Updated: | 12/8/2018 |
| Start Date: | March 11, 2016 |
| End Date: | September 29, 2017 |
A Randomized, Double-Blind, Vehicle-Controlled, Parallel-Design, Multiple-Site, Phase III Clinical Study to Evaluate the Efficacy and Safety of DSXS Topical Product in Patients With Mild to Severe Scalp Psoriasis
A Randomized, Double-Blind, Vehicle-Controlled, Parallel-Design, Multiple-Site, Phase III
Clinical Study to Evaluate the Efficacy and Safety of DSXS topical product in Patients with
Mild to Severe Scalp Psoriasis
Clinical Study to Evaluate the Efficacy and Safety of DSXS topical product in Patients with
Mild to Severe Scalp Psoriasis
To evaluate the therapeutic efficacy and safety of DSXS topical product (Taro
Pharmaceuticals, U.S.A., Inc.) compared to a Vehicle topical product (Taro Pharmaceuticals,
U.S.A., Inc.) in patients with mild to severe scalp psoriasis.
Pharmaceuticals, U.S.A., Inc.) compared to a Vehicle topical product (Taro Pharmaceuticals,
U.S.A., Inc.) in patients with mild to severe scalp psoriasis.
Inclusion Criteria:
- Male or non-pregnant, non-lactating females 18 years of age and older.
Exclusion Criteria:
- Females who are pregnant, lactating or likely to become pregnant during the study.
We found this trial at
1
site
Click here to add this to my saved trials
